EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Achilles' heel for methicillin-resistant Staphylococcus aureus ? Re-evaluating β-lactam susceptibility of MRSA

Neta Petersiel iD, Benjamin P Howden iD, Stefano Giulieri iD, Steven Y C Tong iD

Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)

DOI: 10.1128/aac.00374-26 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von Neta Petersiel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australi…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, beta-Lactams. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) infections (i.e., carrying the mec gene) are challenging to treat due to their inherent resistance to most antistaphylococcal β-lactams. Given the poor outcome of severe MRSA infections and limitations of the current approved treatments, there is growing interest in repurposing β-lactams as part of a treatment strategy for these infections. Here, we review the current literature on β-lactam susceptibility phenotypes in MRSA. We describe four phenotypes: oxacillin-susceptible, sensitivity to combinations of β-lactam-β-lactamase inhibitors, NaHCO 3 responsiveness, and synergy between classes of β-lactams that target different penicillin-binding proteins. For each phenotype, we discuss the genetic background, known explanatory biological mechanisms, and associations between MRSA β-lactam susceptibility phenotype and treatment response to β-lactam therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusAnti-Bacterial Agentsbeta-LactamsMicrobial Sensitivity TestsHumansStaphylococcal Infectionsbeta Lactam AntibioticsOxacillinPenicillin-Binding Proteinsbeta-Lactamase InhibitorsPhenotype

Stichwörter der Autor:innen

MRSAphenotypesβ-lactams

Substanzen

Anti-Bacterial Agentsbeta-Lactamsbeta Lactam AntibioticsOxacillinPenicillin-Binding Proteinsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
  • Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

ORCID-Profile: Neta Petersiel, Benjamin P Howden, Stefano Giulieri, Steven Y C Tong

Zitieren

APA

Petersiel, N., Howden, B. P., Giulieri, S., & Tong, S. Y. C. (2026). An Achilles' heel for methicillin-resistant Staphylococcus aureus ? Re-evaluating β-lactam susceptibility of MRSA. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00374-26

Vancouver

Petersiel N, Howden BP, Giulieri S, Tong SYC. An Achilles' heel for methicillin-resistant Staphylococcus aureus ? Re-evaluating β-lactam susceptibility of MRSA. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00374-26

BibTeX
@article{Petersiel2026,
  author = {Petersiel, Neta and Howden, Benjamin P and Giulieri, Stefano and Tong, Steven Y C},
  title = {An Achilles' heel for methicillin-resistant Staphylococcus aureus ? Re-evaluating β-lactam susceptibility of MRSA},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {8},
  doi = {10.1128/aac.00374-26}
}
Kostenlos starten →